生命科学资讯

Capricor's phase 3 win sets up 2nd approval attempt for Duchenne cell therapy

FDA seeks to raise user fees for companies running Phase 1 trials outside the US

Biologics CDMO Market Trends and Investment Forecast to 2033: Features Analysis of Lonza Group, Cata - PharmiWeb.com

FDA says it won't release details of claimed Covid vaccine deaths in 'near term'

10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga

After finding ‘irregularities,’ Bristol Myers to extend key trial of Cobenfy in Alzheimer’s psychosis

Appointments and advancements for Dec. 3, 2025

Financings for Dec. 3, 2025

In the clinic for Dec. 3, 2025

Other news to note for Dec. 3, 2025

Regulatory actions for Dec. 3, 2025

With Phase 3 Duchenne success, Capricor plots path forward after FDA rejection

Black Diamond reports mid-stage lung cancer data, continues its hunt for a partner

Capricor soars on positive results for Duchenne cell therapy

Membrane potential mediates the cellular response to mechanical pressure

The unique architecture of umbrella toxins permits a two-tiered molecular bet-hedging strategy for interbacterial antagonism

A stepwise decoding mechanism for heat sensing in plants connects lipid remodeling to a nuclear signaling cascade

pTα enhances mRNA translation and potentiates CAR T cells for solid tumor eradication

The effect of shingles vaccination at different stages of the dementia disease course

Olympus-backed robotics startup Swan EndoSurgical taps Stryker vet for CEO